contrast media injectors, angiographic contrast injector

Automated contrast media injectors are used in cardiac imaging to help improve patient safety and enhance image quality. These devices control contrast dosage, record the amount used, speed injections to keep up with fast CT scanners, and warn of potential hazards, such as air embolisms or extravasations. Key Differences in Injectors

July 8, 2010 – Siemens Healthcare recently announced the 2.0 release of its Acuson S2000 ultrasound system, with applications across general imaging, including obstetrics and gynecology (OB/GYN), as well as vascular and cardiac imaging.

The new release features:
• Next generation tissue strain analytics, including Virtual Touch HD technology and

July 8, 2010 – A new consensus statement released recently by the Heart Rhythm Society (HRS) offers guidance for managing cardiovascular implantable electronic devices (CIEDs) in patients nearing end of life or requesting device deactivation.

July 8, 2010 – The first patients have enrolled in an European pilot study to test an implantable device meant to help regulate sleep-disorder breathing in heart failure patients, Cardiac Concepts Inc. announced this week. The trial will examine the respiratory and cardiac benefits of Cardiac Concepts’ RespiCardia System when treating central sleep apnea (CSA) in patients with heart failure.

July 8, 2010 – Newly published guidelines should help cardiologists better evaluate the right heart, the American Society of Echocardiography announced this week. The new guidelines, published in the July issue of the Journal of the American Society of Echocardiography (JASE), seek to establish a more uniform method of evaluating the size and function of the right ventricle.

July 8, 2010 – Boston Scientific Corp. today announced enrollment of the first patient in its MultiSENSE clinical trial, which the company plans to use to develop a clinical alert identifying the early onset of worsening heart failure. The trial is designed to evaluate multiple physiologic sensors in the company’s Cognis cardiac resynchronization therapy defibrillators (CRT-Ds).

July 8, 2010 – The Canadian Nuclear Safety Commission (CNSC) announced this week it has authorized the reactivation of the National Research Universal (NRU) reactor in Chalk River, Ontario, Canada. It is estimated that NRU will resume medical isotope production by the end of July, after being shut down in 2009 for several repairs.

Pulmonary embolism (PE) is generally treated with blood thinners, but a more aggressive treatment may be required for massive PE in hemodynamically compromised patients, said Ali Amin, M.D., a vascular surgeon at The Read Hospital and Medical Center in Reading, Pa.

Percutaneous mechanical thrombectomy (PMT) devices are increasingly being used to remove clots from coronary and peripheral vessels. They offer a faster treatment option than using traditional systemic thrombolytic (lytic) or catheter-directed thrombolysis (CDT).

OSF HealthCare System, owned and operated by The Sisters of the Third Order of St. Francis, Peoria, Ill., is a seven-hospital enterprise serving 2.5 million patients throughout Illinois and Michigan.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now